Vismodegib for Locally Advanced Basal Cell Carcinoma in a Heart Transplant Patient

Importance  Immunosuppressed patients with solid organ transplants have an increased risk for nonmelanoma skin cancer. Vismodegib has been reported to be effective for select locally advanced or metastatic basal cell carcinomas. However, there is no data documenting the use and … Continued

Source: JAMA Oncology - October 24, 2014 Category: Cancer & Oncology Authors: Carrie Ann Cusack, MD and colleagues Tags: Case Report/Case Series JAMA Dermatology Research Source Type: research